Key result
Abstract lacks clinical data to determine bariatric surgery's impact on the dexamethasone suppression test.
Key points are not available for this paper at this time.
Cannot inform DST use after bariatric surgery; leaves open effects on cortisol suppression in severe obesity.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Casteràs et al. (2023) studied this question. Bariatric surgery's impact on the 1mg dexamethasone suppression test in severe obesity cannot be determined because the provided abstract contains no clinical data or results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: